NIBR chief Jay Bradner joins the exodus at Novartis, handing the keys to Fiona Marshall

John Carroll

Editor & Founder

Seven years ago, Jay Bradner left high-profile posts at Harvard Med and Dana-Farber and jumped to the leadership role at Novartis’ global research arm, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

NIBR chief Jay Bradner joins the exodus at Novartis, handing the keys to Fiona Marshall

John Carroll

Editor & Founder

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

At least seven drugmakers say they will participate in round two of IRA negotiations

Trump’s science crackdown hits rare disease research: ‘We need to sit down with Elon Musk’

Exclusive: Infectious disease doctors consider 'mini-ACIP' if RFK erodes CDC vaccine panel

Bipartisan 'pill penalty' fix and other bills vie for inclusion in reconciliation package

Lilly joins molecular glue field with Magnet deal worth up to $1.25B

How AI can address ongoing challenges in the life sciences industry

NI­BR chief Jay Brad­ner joins the ex­o­dus at No­var­tis, hand­ing the keys to Fiona Mar­shall

Editor & Founder

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

NIBR chief Jay Bradner joins the exodus at Novartis, handing the keys to Fiona Marshall